Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 67 of 67 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/01/17
End: 03/31/20
Due: 03/31/21
Phase: N/A
Priority: Normal
Start: 03/20/17
End: 09/19/20
Due: 09/19/21
Phase: N/A
Priority: Normal
Start: 04/15/17
End: 11/15/19
Due: 11/15/20
Phase: N/A
Priority: Normal
Start: 05/06/24
End: 03/31/26
Due: 03/31/27
Phase: N/A
Priority: Normal
Start: 08/01/18
End: 12/01/20
Due: 12/01/21
Effects of Nattokinase on Inflammation and Cardiovascular Risk Markers in Patients With Dyslipidemia
Phase: N/A
Priority: Normal
Start: 08/03/24
End: 07/31/26
Due: 07/31/27
Phase: N/A
Priority: Normal
Start: 05/29/14
End: 06/20/14
Due: 06/20/15
Phase: N/A
Priority: Normal
Start: 03/01/13
End: 12/01/19
Due: 12/01/20
Phase: N/A
Priority: Normal
Start: 10/01/24
End: 07/31/27
Due: 07/31/28
Phase: N/A
Priority: Normal
Start: 01/31/13
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 08/14/23
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 04/10/24
End: 12/10/26
Due: 12/10/27
Phase: N/A
Priority: Normal
Start: 01/31/14
End: 01/31/16
Due: 01/31/17
Phase: N/A
Priority: Normal
Start: 12/31/22
End: 02/28/23
Due: 02/28/24
Phase: N/A
Priority: Normal
Start: 07/31/14
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 01/15/17
End: 01/05/20
Due: 01/05/21
Phase: N/A
Priority: Normal
Start: 07/30/24
End: 04/05/26
Due: 04/05/27